IMPACT BIOMEDICAL INC. — Form 8-K
Filed October 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Impact Biomedical Inc. filed an 8-K on October 9, 2026 reporting amendments to its articles of incorporation or bylaws (Item 5.03), effective September 23, 2026. The filing does not disclose specific bylaw changes, dollar amounts, or operational impacts in the text provided; only that amendments occurred and confirms a December 31 fiscal year end. No counterparties, financial figures, or quantifiable business changes are specified.
Why this rating
Routine corporate governance filing with no disclosed operational, financial, or strategic impact; typical administrative disclosure for a small-cap company.
Extracted items
- 5.03 charter/bylaw change
- 9.01 exhibits
See more from October 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.